🇺🇸 FDA
Patent

US 9073851

Compositions and methods for treating cancer

granted A61KA61K31/404A61K31/437

Quick answer

US patent 9073851 (Compositions and methods for treating cancer) held by The Board of Regents of the University of Texas System expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/404, A61K31/437, A61K45/06, A61P